Artificial intelligence is here. AI-driven capabilities that not too long ago may have seemed like science fiction are now being ...

The meticulous art of R&D demands extensive collaboration, mastery of technical skills, and scientific acumen. In and of itself, the ...

For pharmaceutical and biotechnology companies focusing on research and development, prioritizing data transparency and clinical study reporting (CSR) is a ...

Day after day, headline after headline, blockchain is referenced as a solution for an array of complex challenges facing businesses ...

The advent of personalized medicine is a result of countless innovations in an array of fields, including genomic sequencing, big ...

In recent news, Pfizer Chief Executive Officer Ian Read stated he will step down at the end of 2018 after ...

In July, the NIH officially partnered with Google Cloud to launch STRIDES (Science and Technology Research Infrastructure for Discovery, Experimentation, ...

Excellent drug development is critical today, as patients across the world are relying on innovative new treatments and therapies to ...

Pharmaceutical organizations looking to grow into personalized medicine are leveraging high-dollar acquisitions of cell therapy companies to quickly enter the ...

This week, PhRMA, the country’s leading biopharmaceutical research industry group made a bold statement about bringing down the cost of medicines. In ...

Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of RNA interference therapeutics for genetically ...

The shift to personalized medicine, where companies can develop preventive measures and precision treatments to enhance a patient’s unique well-being, ...